Champions Oncology, Inc. (CSBR) Institutional Ownership

Ownership Summary

Champions Oncology, Inc. (NASDAQ:CSBR) has 27 institutional investors with active 13F positions as of December 2025.

• These investors collectively held 39.8% of Champions Oncology's outstanding shares in December 2025, down from 41.2% in September 2025.
• They increased total shares held in Champions Oncology by 1.92% from the prior quarter, while the number of investors in CSBR increased 3.85% year over year.
• Activity in CSBR broke down as 9 buyers, 9 sellers, and 9 unchanged among 27 total holders.
• Altogether, these fund groups held 5.75Mn shares in CSBR by December 2025, up by 108.58K shares quarter on quarter, and down 41.05K shares year over year.
• Battery Management Corp. leads ownership in CSBR with 2.42Mn shares as of December 31, 2025, equal to 16.75% of outstanding shares.
• Leading buyers of Champions Oncology shares for the quarter ending December 2025 were VANGUARD CAPITAL MANAGEMENT LLC (299.52K), VANGUARD FIDUCIARY TRUST CO (32.99K), Mink Brook Asset Management LLC (31.03K), Morgan Stanley (12.64K), Mesirow Financial Investment Management, Inc. (5.5K).
• Top sellers of CSBR stock for the quarter ending December 2025 included RENAISSANCE TECHNOLOGIES LLC (9.3K), ACADIAN ASSET MANAGEMENT LLC (8.67K), Bank of New York Mellon Corp (5.14K), DIMENSIONAL FUND ADVISORS LP (1.38K), Northern Trust Corp (214).
• Per Business Quant, the top 10 investors in CSBR for the quarter ending December 2025 include Battery Management Corp. (2.42Mn), NEA Management Company, LLC (1.71Mn), TOCQUEVILLE ASSET MANAGEMENT L.P. (319.67K), VANGUARD CAPITAL MANAGEMENT LLC (299.52K), Morgan Stanley (242.3K), RENAISSANCE TECHNOLOGIES LLC (145.54K), BlackRock, Inc. (123.9K), Mink Brook Asset Management LLC (111.34K), GEODE CAPITAL MANAGEMENT, LLC (77.18K), Northern Trust Corp (45.93K).